期刊
EMBO MOLECULAR MEDICINE
卷 5, 期 1, 页码 52-63出版社
WILEY
DOI: 10.1002/emmm.201201923
关键词
Alzheimer's disease; cognition; epigenetics; histone deacetylase; neurodegeneration
资金
- EURYI
- Schram Foundation
- Hans and Ilse Breuer Foundation
- ERA Net Neuron Project Epitherapy
- German Center for Neurodegenerative Diseases (DZNE) Goettingen
- EMJD - European Neuroscience Campus Network
Histone deacetylases (HDACs) are currently being discussed as promising therapeutic targets to treat neurodegenerative diseases. However, the role of specific HDACs in cognition and neurodegeneration remains poorly understood. Here, we investigate the function of HDAC6, a class II member of the HDAC superfamily, in the adult mouse brain. We report that mice lacking HDAC6 are cognitively normal but reducing endogenous HDAC6 levels restores learning and memory and a-tubulin acetylation in a mouse model for Alzheimer's disease (AD). Our data suggest that this therapeutic effect is, at least in part, linked to the observation that loss of HDAC6 renders neurons resistant to amyloid-beta-mediated impairment of mitochondrial trafficking. Thus, our study suggests that targeting HDAC6 could be a suitable strategy to ameliorate cognitive decline observed in AD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据